Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.78 USD | 0.00% | -3.08% | -33.80% |
11/03 | AbCellera, Biogen Collaborate to Discover Treatments for Neurological Diseases | MT |
11/03 | AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.80% | 1.11B | |
+0.67% | 42.4B | |
+44.30% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- ABCL Stock
- News AbCellera Biologics Inc.
- AbCellera Biologics : Swings to Q2 Loss; Revenue Rises